National Audit of Cardiac Rhythm Management Devices and Ablation – 2016-17 Report
This report presents the official record of invasive cardiology procedures for cardiac rhythm management (CRM) between 1st April 2016 and 31st March 2017. This is also the first year of a planned programme to increase the focus on quality improvement (QI) and outcomes (clinical and technical) of CRM device procedures, which links more closely with the wider National Cardiac Audit Programme (NCAP) and related national initiatives.
The national CRM annual report details clinical activity in the fields of:
- Permanent pacemakers (PPMs – for the treatment of blackouts and other symptoms)
- Implantable cardioverter defibrillators (ICDs – for the prevention of sudden cardiac death)
- Cardiac resynchronisation therapy (CRT – for the treatment of heart failure, cardiac resynchronisation therapy with defibrillation (CRT-D) or pacing (CRTP))
- Catheter ablation (for the treatment of simple, complex atrial, and ventricular arrhythmias)
This report describes activity and outcomes around three key quality improvement themes which run through the wider NCAP report. These are:
- Patient outcomes – what can we do to improve patient outcomes?
- Safety – how can services be made safer?
- Clinical effectiveness – are the best treatments being used and is care being delivered effectively?
Click below to read the full report.